[1] S. N. Cohen, “Bacterial Plasmids: Their Extraordinary Contribution to Molecular Genetics,” Gene, Vol. 135, No. 1-2, 1993, pp. 67-76. doi:10.1016/0378-1119(93)90050-D
[2] O. Tolmachov, “Designing Plasmid Vectors,” Methods in Molecular Biology, Vol. 542, 2009, pp. 117-129. doi:10.1007/978-1-59745-561-9_6
[3] B. Guo and Y. Bi, “Cloning PCR Products. An Overview,” Methods in Molecular Biology, Vol. 192, 2002, pp. 111-119.
[4] J. Sambrook, E. F. Fritsch and T. Maniatis, “Molecular Cloning: A Laboratory Manual,” Spring Harbor Laboratory Press, New York, 1989.
[5] Z. G. Liu and L. M.Schwartz, “An Efficient Method for Blunt-End Ligation of PCR Products,” Biotechniques, Vol. 12, No. 1, 1992, pp. 28-30.
[6] A. Ullmann, “Complementation in Beta-Galactosidase: from Protein Structure to Genetic Engineering,” Bioessays, Vol. 14, No. 3, 1992, pp. 201-205. doi:10.1002/bies.950140311
[7] J. Vieira and J. Messing, “The pUC Plasmids, an M13mp7Derived System for Insertion Mutagenesis and Sequencing with Synthetic Universal Primers,” Gene, Vol. 19, No. 3, 1982, pp. 259-268. doi:10.1016/0378-1119(82)90015-4
[8] P. Bernard, P. Gabant, E. M. Bahassi and M. Couturier, “Positive-Selection Vectors Using the F Plasmid ccdB Killer Gene,” Gene, Vol. 148, No. 1, 1994, pp. 71-74. doi:10.1016/0378-1119(94)90235-6
[9] B. Henrich and B. Schmidtberger, “Positive-Selection Vector with Enhanced Lytic Potential Based on a Variant of Phi X174 Phage Gene E,” Gene, Vol. 154, No. 1, 1995, pp. 51-54.
[10] P. Kast, “pKSS—A Second-Generation General Purpose Cloning Vector for Efficient Positive Selection of Recombinant Clones,” Gene, Vol. 138, No. 1-2, 1994, 109-114. doi:10.1016/0378-1119(94)90790-0
[11] S. A. Yazynin, S. M. Deyev, M. Jucovic and R. W. Hartley, “A Plasmid Vector with Positive Selection and Directional Cloning Based on a Conditionally Lethal Gene,” Gene, Vol. 169, No. 1, 1996, pp. 131-132.
[12] D. F. Gruber, V. A. Pieribone, B. Porton and H. T. Kao, “Strict Regulation of Gene Expression from a High-Copy Plasmid Utilizing a Dual Vector System,” Protein Expression and Purification, Vol. 60, No. 1, 2008, pp. 53-57.
[13] P. Bernard and M. Couturier, “Cell Killing by the F Plasmid ccdB Protein Involves Poisoning of DNA-Topoisomerase П Complexes,” Journal of Molecular Biology, Vol. 226, No. 3, 1992, pp. 735-745.
[14] R. A. Schuepbach, J. Madon, M. Ender, P. Galli and M. Riewald, “Protease Activated Receptor-1 Cleaved at R46 Mediates Cytoprotective Effects,” Journal of Thrombosis and Haemostasis, 2012. doi:10.1111/j.1538-7836.2012.04825.x
[15] R. A. Schuepbach and M. Riewald, “Coagulation Factor Xa Cleaves Protease-Activated Receptor-1 and Mediates Signaling Dependent on Binding to the Endothelial Protein C Receptor,” Journal of Thrombosis and Haemostasis, Vol. 8, No. 2, 2010, pp. 379-388.
[16] K. Miyazaki, “Lethal ccdB Gene-Based Zero-Background Vector for Construction of Shotgun Libraries,” Journal of Bioscience and Bioengineering, Vol. 110, No. 3, 2010, pp. 372-373.
[17] S. Shuman, “Recombination Mediated by Vaccinia Virus DNA Topoisomerase I in Escherichia coli Is Sequence Specific,” Proceedings of National Academy of Science of USA, Vol. 88, No. 22, 1991, pp. 10104-10108. doi:10.1073/pnas.88.22.10104